HER2 Support Group Forums - FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrenc

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- General Cancer News (https://her2support.org/vbulletin/forumdisplay.php?f=45)

- - FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrenc (https://her2support.org/vbulletin/showthread.php?t=66309)

News	07-17-2017 09:42 PM

FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrenc

The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer.

More...

All times are GMT -7. The time now is 08:29 AM.